Resmetirom for MASH patients with diabetes: challenges and opportunities in the real world.

Metabolism

MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou 325000, China. Electronic address:

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.metabol.2024.155935DOI Listing

Publication Analysis

Top Keywords

resmetirom mash
4
mash patients
4
patients diabetes
4
diabetes challenges
4
challenges opportunities
4
opportunities real
4
resmetirom
1
patients
1
diabetes
1
challenges
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!